Overview

Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia

Status:
Not yet recruiting

Trial end date:
2020-10-04

Target enrollment:

Participant gender:

Summary

Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, associated with standards treatments in COVID-19 (+) patients, Hospitalized In Intensive care in Tunisia. Multicentric, comparative, randomized study.

Phase:

Phase 3

Details

Lead Sponsor:

Abderrahmane Mami Hospital

Collaborators:

Datametrix
Eshmoun Clinical Research Centre

Treatments:

Deferoxamine